BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 867045)

  • 1. Somatostatin: analogs with selected biological activities.
    Brown M; Rivier J; Vale W
    Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
    Karashima T; Cai RZ; Schally AV
    Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibitory effect of the analog D5-F-TrP8-D-Cys14 somatostatin on the arginine induced release of insulin, growth hormone and glucagon, in normal human beings.
    González-Bárcena D; Mendoza F; Graef A; Medina R; Comaru-Schally AM; Schally AV
    Arch Invest Med (Mex); 1985; 16 Suppl 3():105-14. PubMed ID: 2878649
    [No Abstract]   [Full Text] [Related]  

  • 4. An in vivo model for testing inhibition of arginine-induced insulin and glucagon release by somatostatin analogs.
    Gordin A; Meyers C; Arimura A; Coy DH; Schally AV
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):833-41. PubMed ID: 335762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-Trp8-somatostatin: an analog of somatostatin more potent than the native molecule.
    Rivier J; Brown M; Vale W
    Biochem Biophys Res Commun; 1975 Jul; 65(2):746-51. PubMed ID: 1096897
    [No Abstract]   [Full Text] [Related]  

  • 6. Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release.
    Meyers C; Arimura A; Gordin A; Fernandez-Durango R; Coy DH; Schally AV; Drouin J; Ferland L; Beaulieu M; Labrie F
    Biochem Biophys Res Commun; 1977 Jan; 74(2):630-6. PubMed ID: 836315
    [No Abstract]   [Full Text] [Related]  

  • 7. Observations on the growth hormone, insulin, and glucagon release-inhibiting activities of somatostatin analogues.
    Coy DH; Meyers C; Arimura A; Schally AV; Redding TW
    Metabolism; 1978 Sep; 27(9 Suppl 1):1407-10. PubMed ID: 683009
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat.
    Brown M; Rivier J; Vale W
    Endocrinology; 1976 Feb; 98(2):336-43. PubMed ID: 813991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Natural peptides and their analogs. XXXV. Synthesis and properties of [Ala5, Orn9]somatostatin].
    Shvachkin IuP; Smirnova AP; Ermak NM; Fedotov VP; Sadovnikova NV
    Bioorg Khim; 1985 Aug; 11(8):1026-36. PubMed ID: 2865960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin analogs inhibit somatostatin release.
    Ipp E; Rivier J; Dobbs RE; Brown M; Vale W; Unger RH
    Endocrinology; 1979 May; 104(5):1270-3. PubMed ID: 436775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent, highly selective inhibition of growth hormone secretion by position 4 somatostatin analogs.
    Murphy WA; Meyers CA; Coy DH
    Endocrinology; 1981 Aug; 109(2):491-5. PubMed ID: 6113951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative effects of somatostatin and two somatostatin analogues on the release of insulin, glucagon and growth hormone.
    Efendić S; Luft R; Sievertsson H
    FEBS Lett; 1975 Oct; 58(1):302-5. PubMed ID: 1225595
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of somatostatin and two of its analogues on basal and arginine-stimulated insulin and glucagon secretion in the dog.
    Buchs A; Märki F; Keller U
    Regul Pept; 1982 Aug; 4(3):117-26. PubMed ID: 6127755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective effect of some somatostatin analogs on glucagon as opposed to insulin release in rats in vivo.
    Lins PE; Efendić S; Meyers CA; Coy DH; Schally A; Luft R
    Metabolism; 1980 Aug; 29(8):728-31. PubMed ID: 6105610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of somatostatin effects. Peptides inhibiting the release of growth hormone but not glucagon or insulin in rats.
    Grant N; Clark D; Garsky V; Jaunakais I; McGregor W; Sarantakis D
    Life Sci; 1976 Sep; 19(5):629-31. PubMed ID: 957897
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release.
    Meyers CA; Coy DH; Murphy WA; Redding TW; Arimura A; Schally AV
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):577-9. PubMed ID: 6987657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosylated analogues of somatostatin.
    Rivier JE; Brown MR; Vale WW
    J Med Chem; 1976 Aug; 19(8):1010-3. PubMed ID: 966246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-selective inhibition of basal glucagon release by [D-Cys14]-analogues of somatostatin in the rat.
    Märki F; Kamber B; Rink H; Sieber P
    J Endocrinol; 1979 Jun; 81(3):315-23. PubMed ID: 469462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of glycosylated analogs of somatostatin.
    Lavielle S; Ling N; Brazeau P; Benoit R; Wasada T; Harris D; Unger R; Guillemin R
    Biochem Biophys Res Commun; 1979 Nov; 91(2):614-22. PubMed ID: 518658
    [No Abstract]   [Full Text] [Related]  

  • 20. Biologic and immunologic activities and applications of somatostatin analogs.
    Vale W; Rivier J; Ling N; Brown M
    Metabolism; 1978 Sep; 27(9 Suppl 1):1391-401. PubMed ID: 210361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.